High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$23.8M
$23,770,752
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARWR
S
ARROWHEAD PHARMACEUTICALS, INC.
Hamilton James C
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-05
$641,900
|
||||||
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-05 | $641,900 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-12-22 | $684,120 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-12-22 | $177,220 | S | Form 4 |
|
ARWR
S
ARROWHEAD PHARMACEUTICALS, INC.
OLUKOTUN ADEOYE Y
• Director
10b5-1 SellΔOwn -15.0%
2025-12-19
$413,887
|
||||||
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -15.0%
|
2025-12-19 | $413,887 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-19 | $206,103 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-19 | $56,633 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-12-19 | $265,280 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-12-19 | $554,077 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-12-19 | $90,325 | S | Form 4 |
|
ARWR
S
ARROWHEAD PHARMACEUTICALS, INC.
Waddill William D.
• Director
10b5-1 Sell
2025-12-19
$161,051
|
||||||
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-19 | $161,051 | S | Form 4 |
|
ARWR
S
ARROWHEAD PHARMACEUTICALS, INC.
Waddill William D.
• Director
10b5-1 Sell
2025-12-19
$370,723
|
||||||
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-19 | $370,723 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-19 | $34,265 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-19 | $186,497 | S | Form 4 |
|
ARWR
S
ARROWHEAD PHARMACEUTICALS, INC.
Vakiener Victoria
• Director
10b5-1 SellΔOwn -12.3%
2025-12-19
$358,950
|
||||||
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 SellΔOwn -12.3%
|
2025-12-19 | $358,950 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-12-19 | $134,044 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-17 | $131,340 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-17 | $2,941,539Large | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-17 | $2,306,232Large | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-17 | $64,350 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $85,501 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $218,609 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $11,084 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $509,252 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $671,484 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $875,581 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $533,479 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $428,236 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-16 | $64,960 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-15 | $1,477,119Large | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-15 | $569,964 | S | Form 4 |
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
CEO
Discretionary Sell
|
2025-12-15 | $6,903,532Whale | S | Form 4 |
|
ARWR
S
ARROWHEAD PHARMACEUTICALS, INC.
Ferrari Mauro
• Director
Discretionary SellΔOwn -11.3%
2025-11-28
$493,412
|
||||||
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Director
Discretionary SellΔOwn -11.3%
|
2025-11-28 | $493,412 | S | Form 4 |
|
ARWR
S
ARROWHEAD PHARMACEUTICALS, INC.
Hamilton James C
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-01
$700,000
|
||||||
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-01 | $700,000 | S | Form 4 |
|
ARWR
S
ARROWHEAD PHARMACEUTICALS, INC.
Hamilton James C
• Officer • Chief Medical Officer
10b5-1 Sell
2025-09-12
$450,000
|
||||||
| ARWR |
ARROWHEAD PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-09-12 | $450,000 | S | Form 4 |